Elutia Inc (ELUT)

Mar 14, 2026

Elutia (ELUT) Grants Stock Options to New Hires - GuruFocus

Mar 14, 2026

Mar 14, 2026

Elutia announces grants of inducement awards - TipRanks

Mar 14, 2026

Mar 13, 2026

Exit Recap: Is Elutia Inc subject to activist investor interest2026 Market Mood & Detailed Earnings Play Strategies - baoquankhu1.vn

Mar 13, 2026

Mar 13, 2026

Elutia 2025 10-K: Revenue $12.3M, EPS (cont. ops) $(15.871)M - TradingView

Mar 13, 2026

Mar 13, 2026

Elutia (NASDAQ: ELUT) pivots to drug‑eluting biomatrix after asset divestitures - Stock Titan

Mar 13, 2026

Mar 13, 2026

Achieving Micron-Level Tolerances: CAD Optimization for Sub-10µm 3D Printing - AOL.com

Mar 13, 2026

Mar 13, 2026

Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - Bitget

Mar 13, 2026

Mar 13, 2026

Elutia markets another product for sale as it pivots to breast reconstruction infection prevention - The Business Journals

Mar 13, 2026

Mar 13, 2026

Elutia grants 460,000 stock options to 3 new hires at $1.09 - Stock Titan

Mar 13, 2026

Mar 13, 2026

Elutia (ELUT) Q4 2025 Earnings Call Transcript - AOL.com

Mar 13, 2026

Mar 13, 2026

Elutia Inc. (NASDAQ:ELUT) Q4 2025 earnings call transcript - MSN

Mar 13, 2026

Mar 12, 2026

[Form 4] ELUTIA INC. Insider Trading Activity - Stock Titan

Mar 12, 2026

Mar 12, 2026

Elutia Q4 2025 slides: $88M sale funds pivot to breast reconstruction - Investing.com Australia

Mar 12, 2026

Mar 12, 2026

Elutia Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:ELUT) 2026-03-12 - Seeking Alpha

Mar 12, 2026

Mar 12, 2026

Elutia Reports Strong 2025 Financial Results, Advances NXT-41x for Breast Cancer Surgery, and Closes $88M BioEnvelope Sale to Boston Scientific - Minichart

Mar 12, 2026

Mar 12, 2026

Elutia Inc (ELUT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Moves Amid ... By GuruFocus - Investing.com Canada

Mar 12, 2026

Mar 11, 2026

Elutia Inc (ELUT) Q4 2025 Earnings Call Highlights: Revenue Grow - GuruFocus

Mar 11, 2026

Mar 11, 2026

Elutia Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 11, 2026

Mar 11, 2026

Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process - Bitget

Mar 11, 2026

Mar 11, 2026

Earnings call transcript: Elutia Q4 2025 beats forecasts, stock steady By Investing.com - Investing.com Australia

Mar 11, 2026

Mar 11, 2026

Earnings call transcript: Elutia Q4 2025 beats forecasts, stock steady - Investing.com India

Mar 11, 2026

Mar 11, 2026

Elutia Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 11, 2026

Mar 11, 2026

Elutia earnings beat by $1.60, revenue topped estimates - Investing.com Canada

Mar 11, 2026

Mar 11, 2026

Elutia reports $3.3M Q4 revenue, $70.8M net income on BioEnvelope sale; $44.4M year-end cash - TradingView

Mar 11, 2026

Mar 11, 2026

ELUTIA ($ELUT) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative

Mar 11, 2026

Mar 11, 2026

Elutia Q4 revenue rises on higher cardiovascular product sales - TradingView

Mar 11, 2026

Mar 11, 2026

ELUT: Q4 net income soared to $70.8M on BioEnvelope sale, with NXT-41x FDA process underway - TradingView

Mar 11, 2026

Mar 10, 2026

Elutia Inc. Adopts 2026 Inducement Award Plan and Files Form 8-K Disclosure - Minichart

Mar 10, 2026

Mar 10, 2026

Exploring Elutia's Earnings Expectations - Benzinga

Mar 10, 2026

Mar 10, 2026

Elutia Inc (ELUT) Q4 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus

Mar 10, 2026

Mar 09, 2026

Elutia Adopts 2026 Inducement Equity Award Plan - TipRanks

Mar 09, 2026

Mar 09, 2026

Elutia Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView

Mar 09, 2026

Mar 06, 2026

Elutia Regains Full Nasdaq Compliance, Strengthening Listing Status - The Globe and Mail

Mar 06, 2026

Mar 05, 2026

Elutia (ELUT) Expected to Announce Earnings on Wednesday - MarketBeat

Mar 05, 2026

Mar 04, 2026

Elutia regains compliance with Nasdaq listing requirements - Investing.com Australia

Mar 04, 2026

Mar 04, 2026

Elutia regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Canada

Mar 04, 2026

Mar 04, 2026

Elutia regains Nasdaq compliance after meeting minimum bid price and MVLS - TradingView

Mar 04, 2026

Mar 04, 2026

Elutia Regains Compliance with Nasdaq Listing Requirements - Bitget

Mar 04, 2026

Mar 04, 2026

Elutia (NASDAQ: ELUT) regains full Nasdaq listing compliance after bid price, value breach - Stock Titan

Mar 04, 2026

Mar 03, 2026

Elutia names Pete Ligotti chief commercial officer - Investing.com

Mar 03, 2026

Mar 02, 2026

Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market - Bitget

Mar 02, 2026

Mar 02, 2026

Elutia Selects Pete Ligotti as CCO to Lead the Commercial - GlobeNewswire

Mar 02, 2026

Mar 02, 2026

Elutia names Pete Ligotti chief commercial officer By Investing.com - Investing.com UK

Mar 02, 2026

Feb 27, 2026

ELUT Should I Buy - Intellectia AI

Feb 27, 2026

Feb 25, 2026

Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026 - Bitget

Feb 25, 2026

Feb 25, 2026

ELUT SEC FilingsElutia Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Feb 25, 2026

Feb 25, 2026

Elutia schedules March 11 webcast for Q4 2025 financials - Stock Titan

Feb 25, 2026

Feb 24, 2026

ELUT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 24, 2026

Feb 23, 2026

Interview with the President and CEO: Elutia Inc. (NASDAQ:ELUT) - The Wall Street Transcript

Feb 23, 2026

Feb 20, 2026

Short Squeeze: What is the PEG ratio of Brookdale Senior Living IncStock Surge & Free Growth Oriented Trading Recommendations - baoquankhu1.vn

Feb 20, 2026

Feb 19, 2026

Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification - HRTech Series

Feb 19, 2026